Immuno-oncology innovations redefining cancer treatment in 2024
Drug Target Review
JANUARY 23, 2024
Vaccinations against tumour antigens that are shared between tumours, or tumour antigens that arise from mutations unique to individual tumours, represent promising strategies. We anticipate this area to grow, especially cancer vaccines, with important read-outs expected across various cancer types in 2024.
Let's personalize your content